Provided by Tiger Fintech (Singapore) Pte. Ltd.

EyePoint

11.70
+0.19751.72%
Volume:568.87K
Turnover:6.64M
Market Cap:944.17M
PE:-4.31
High:11.79
Open:11.73
Low:11.52
Close:11.50
52wk High:14.91
52wk Low:3.91
Shares:80.72M
Float Shares:54.46M
Volume Ratio:0.59
T/O Rate:1.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7110
EPS(LYR):-2.3246
ROE:-73.95%
ROA:-37.79%
PB:3.84
PE(LYR):-5.03

Loading ...

EyePoint Pharmaceuticals (EYPT) Gets a Buy from Mizuho Securities

TIPRANKS
·
Oct 17

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Oct 16

BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, First Horizon, 60 Degrees

Reuters
·
Oct 15

BUZZ-U.S. STOCKS ON THE MOVE-AMD, Bank of America, Morgan Stanley

Reuters
·
Oct 15

BRIEF-Eyepoint Pharmaceuticals Prices Public Offering Of 11 Million Shares At $12.00 Per Share

Reuters
·
Oct 15

EyePoint Announces Pricing of Public Offering

THOMSON REUTERS
·
Oct 15

EyePoint Pharmaceuticals Inc - Prices Public Offering of 11 Mln Shares at $12.00 per Share

THOMSON REUTERS
·
Oct 15

EyePoint $150M Spot Secondary; price range $12.00-$12.50

TIPRANKS
·
Oct 15

BRIEF-Eyepoint Pharmaceuticals Inc Files For Mixed Shelf Size Not Disclosed - SEC Filing

Reuters
·
Oct 15

EyePoint Pharmaceuticals Inc - Proceeds to Advance Duravyu™ Development for Wet Amd and Dme

THOMSON REUTERS
·
Oct 15

EyePoint Announces Proposed Public Offering of Common Stock

GlobeNewswire
·
Oct 15

EyePoint Pharmaceuticals Launches Phase 3 DURAVYU Program

TIPRANKS
·
Oct 15

EyePoint Pharmaceuticals Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Oct 15

EyePoint Pharmaceuticals Inc - Announces Phase 3 Program Initiation for Duravy in Diabetic Macular Edema

THOMSON REUTERS
·
Oct 15

EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema

GlobeNewswire
·
Oct 15

EyePoint reports inducement grants under NASDAQ listing rule

TIPRANKS
·
Sep 16

EyePoint Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Sep 16

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 16

EyePoint Announces Participation at Upcoming Investor Conferences

GlobeNewswire
·
Aug 26

BRIEF-EyePoint Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Aug 19